Presentation:  Impact of Immunosenescence in Aging MS Patient: Monitoring & Management of Treatment-related Complications
> Pretest


1. Among patients with MS risk for which of the following increases with age?

a. Infection

b. Multiple sclerosis relapses

c. Malignancy

d. Vaccine efficacy

e. A and C

2. Progressive multifocal leukoencephalopathy has been linked to all of the following disease modifying therapies except?

a. Natalizumab

b. Dimethyl fumarate

c. Teriflunomide

d. Fingolimod